Ironwood Pharmaceuticals Inc (IRWD)
5.83
-0.15
(-2.51%)
USD |
NASDAQ |
Jun 14, 16:00
5.835
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Gross Profit (Quarterly)
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 115.78M |
| September 30, 2020 | 103.47M |
| June 30, 2020 | 89.43M |
| March 31, 2020 | 77.70M |
| December 31, 2019 | 115.29M |
| September 30, 2019 | 130.66M |
| June 30, 2019 | 90.90M |
| March 31, 2019 | 67.69M |
| December 31, 2018 | 109.23M |
| September 30, 2018 | 61.07M |
| June 30, 2018 | 77.04M |
| March 31, 2018 | 66.55M |
| December 31, 2017 | 85.22M |
| September 30, 2017 | 80.74M |
| June 30, 2017 | 61.58M |
| March 31, 2017 | 51.64M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 53.31M |
| September 30, 2015 | |
| June 30, 2015 | 27.74M |
| March 31, 2015 | 28.92M |
| December 31, 2014 | 36.33M |
| Date | Value |
|---|---|
| September 30, 2014 | 16.92M |
| June 30, 2014 | -3.678M |
| March 31, 2014 | 12.68M |
| December 31, 2013 | 4.498M |
| September 30, 2013 | 2.911M |
| June 30, 2013 | 6.245M |
| March 31, 2013 | 2.024M |
| December 31, 2012 | 26.02M |
| September 30, 2012 | 96.41M |
| June 30, 2012 | 14.60M |
| March 31, 2012 | 12.25M |
| December 31, 2011 | 32.15M |
| September 30, 2011 | 12.22M |
| June 30, 2011 | 11.26M |
| March 31, 2011 | 10.24M |
| December 31, 2010 | 16.77M |
| September 30, 2010 | 9.059M |
| June 30, 2010 | 9.188M |
| March 31, 2010 | 8.838M |
| December 31, 2009 | 8.404M |
| September 30, 2009 | 15.26M |
| June 30, 2009 | 6.61M |
| March 31, 2009 | 5.231M |
| December 31, 2008 | 4.974M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
77.70M
Minimum
Mar 2020
130.66M
Maximum
Sep 2019
103.32M
Average
103.47M
Median
Sep 2020
Gross Profit (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 96.84M |
| Insmed Inc | 58.04M |
| Altimmune Inc | -- |
| Cassava Sciences Inc | -- |
| InfuSystems Holdings Inc | 16.47M |